Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Neuroimmunology|July 10, 2010
Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalkShekher Mohan, Randall L Davis, Udaya DeSilva, et al.
Journal of Inflammation (London, England)|September 2, 2024
The effects of chronic, continuous β-funaltrexamine pre-treatment on lipopolysaccharide-induced inflammation and behavioral deficits in C57BL/6J miceKarissa Hodge, Daniel J Buck, Subhas Das, et al.
Stress (Amsterdam, Netherlands)|August 21, 2002
Hypoglycemia-induced suppression of luteinizing hormone (LH) secretion in intact female rhesus macaques: role of vasopressin and endogenous opioidsJoaquin Lado-Abeal, Jeffrey A Clapper, B Chen Zhu, et al.
European Journal of Pharmacology|May 27, 2015
The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in miceRandall L Davis, Subhas Das, J Thomas Curtis, et al.
Neurochemistry International|February 5, 2013
Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytesRandall L Davis, Subhas Das, Daniel J Buck, et al.
Neuroscience Letters|September 21, 2010
Neuromelanin inhibits CXCL10 expression in human astroglial cellsNeda Saffarian Tousi, Daniel J Buck, Luigi Zecca, et al.
Journal of Neuroimmunology|May 4, 2007
The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cellsRandall L Davis, Daniel J Buck, Neda Saffarian, et al.
Neuroscience Letters|September 13, 2011
Chronic inorganic mercury exposure induces sex-specific changes in central TNFα expression: importance in autism?J Thomas Curtis, Yue Chen, Daniel J Buck, et al.
Pageof 4